Product
Venetoclax, Azacitidine and Homoharringtonine
1 clinical trial
1 indication
Indication
Acute Myeloid LeukemiaClinical trial
Efficacy and Safety of Venetoclax and Azacitidine Combined With Low-Intensity Homoharringtonine Chemotherapy Followed by Allogeneic Hematopoietic Stem Cell Transplantation in Intermediate/High-Risk Newly Diagnosed Acute Myeloid LeukemiaStatus: Recruiting, Estimated PCD: 2026-07-01